-
1
-
-
84995296300
-
-
2007. http://ganjoho.ncc.go.jp/public/statistics/backnumber/2007-jp.html
-
(2007)
-
-
-
2
-
-
35748946650
-
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
-
Sakuramoto S, Sasako M, Yamaguchi T, et al: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810-1820, 2007.
-
(2007)
N Engl J Med
, vol.357
, pp. 1810-1820
-
-
Sakuramoto, S.1
Sasako, M.2
Yamaguchi, T.3
-
3
-
-
40749153540
-
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial
-
Koizumi W, Narahara H, Hara T, et al: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9: 215-221, 2008.
-
(2008)
Lancet Oncol
, vol.9
, pp. 215-221
-
-
Koizumi, W.1
Narahara, H.2
Hara, T.3
-
4
-
-
0027217474
-
Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
-
Murad AM, Santiago FF, Petroianu A, et al: Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 72: 37-41, 1993. (Pubitemid 23182046)
-
(1993)
Cancer
, vol.72
, Issue.1
, pp. 37-41
-
-
Murad, A.M.1
Santiago, F.F.2
Petroianu, A.3
Rocha, P.R.S.4
Rodrigues, M.A.G.5
Rausch, M.6
-
5
-
-
0028959887
-
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
-
Pyrhönen S, Kuitunen T, Nyandoto P, et al: Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71: 587-591, 1995.
-
(1995)
Br J Cancer
, vol.71
, pp. 587-591
-
-
Pyrhönen, S.1
Kuitunen, T.2
Nyandoto, P.3
-
6
-
-
8044236424
-
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
-
DOI 10.1023/A:1008243606668
-
Glimelius B, Ekström K, Hoffman K, et al: Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8: 163-168, 1997. (Pubitemid 27112884)
-
(1997)
Annals of Oncology
, vol.8
, Issue.2
, pp. 163-168
-
-
Glimelius, B.1
Ekstrom, K.2
Hoffman, K.3
Graf, W.4
Sjoden, P.-O.5
Haglund, U.6
Svensson, C.7
Enander, L.-K.8
Linne, T.9
Sellstrom, H.10
Heuman, R.11
-
7
-
-
9544237136
-
Palliative chemotherapy for advanced gastric cancer
-
DOI 10.1093/annonc/mdh422
-
Wöhrer SS, Raderer M and Hejna M: Palliative chemotherapy for advanced gastric cancer. Ann Oncol 15: 1585-1595, 2004. (Pubitemid 39567288)
-
(2004)
Annals of Oncology
, vol.15
, Issue.11
, pp. 1585-1595
-
-
Wohrer, S.S.1
Raderer, M.2
Hejna, M.3
-
8
-
-
84958728628
-
-
Japanese source
-
-
-
-
9
-
-
0020396015
-
Toxicology and response criteria of the Eastern Cooperative Oncology Group
-
Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655, 1982. (Pubitemid 13149996)
-
(1982)
American Journal of Clinical Oncology: Cancer Clinical Trials
, vol.5
, Issue.6
, pp. 649-655
-
-
Oken, M.M.1
Creech, R.H.2
Davis, T.E.3
-
11
-
-
43249105802
-
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
-
Jassem J, Ramlau R, Santoro A, et al: Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 26: 1698-1704, 2008.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1698-1704
-
-
Jassem, J.1
Ramlau, R.2
Santoro, A.3
|